Abstract

During senescence, Wnt4 expression is down-regulated (unlike their Frizzled receptors), while PPARgamma expression increases in the thymus. Together, these changes allow for thymic degeneration to occur, observed as adipose involution. However, when restored, Wnt4 can efficiently counteract PPARgamma and prevent thymic senescence from developing. The Wnt-pathway activator miR27b has also been reported to inhibit PPARgamma. Our goal was to evaluate the Wnt4 and miR27b levels of Wnt4-transgenic thymic epithelial cell (TEC)-derived exosomes, show their regenerative potential against age-related thymic degeneration, and visualize their binding and distribution both in vitro and in vivo. First, transgenic exosomes were harvested from Wnt4 over-expressing TECs and analyzed by transmission electron microscopy. This unveiled exosomes ranging from 50 to 100 nm in size. Exosomal Wnt4 protein content was assayed by ELISA, while miR27b levels were measured by TaqMan qPCR, both showing elevated levels in transgenic exosomes relative to controls. Of note, kit-purified TEI (total exosome isolate) outperformed UC (ultracentrifugation)-purified exosomes in these parameters. In addition, a significant portion of exosomal Wnt4 proved to be displayed on exosomal surfaces. For functional studies, steroid (Dexamethasone or DX)-induced TECs were used as cellular aging models in which DX-triggered cellular aging was efficiently prevented by transgenic exosomes. Finally, DiI lipid-stained exosomes were applied on the mouse thymus sections and also iv-injected into mice, for in vitro binding and in vivo tracking, respectively. We have observed distinct staining patterns using DiI lipid-stained transgenic exosomes on sections of young and aging murine thymus samples. Moreover, in vivo injected DiI lipid-stained transgenic exosomes showed detectable homing to the thymus. Of note, Wnt4-transgenic exosome homing outperformed control (Wnt5a-transgenic) exosome homing. In summary, our findings indicate that exosomal Wnt4 and miR27b can efficiently counteract thymic adipose involution. Although extrapolation of mouse results to the human setting needs caution, our results appoint transgenic TEC exosomes as promising tools of immune rejuvenation and contribute to the characterization of the immune-modulatory effects of extracellular vesicles in the context of regenerative medicine.

Highlights

  • Transcription factor FoxN1 is the mastermind of thymus organogenesis and identity [1], and is an acknowledged direct molecular target of the glycolipoprotein Wnt4 [2]

  • Along with Wnt4, the Wnt-pathway activator miR27b has been reported to suppress PPARgamma [17, 18, 43, 44]. We have measured both Wnt4 protein and miR27b RNA quantities in transgenic exosomes relative to their control counterparts, using ELISA and TaqMan qPCR methods, respectively. Both Wnt4 and miR27b showed elevated and statistically significant levels in exosomes of transgenic thymic epithelial cell (TEC) compared to their control counterparts

  • The Wnt4 over-expressing transgenic TEC line proves to be a reliable source of transgenic exosomes that are easy to visualize, enrich to high purity, characterize, and apply in experiments

Read more

Summary

Introduction

Transcription factor FoxN1 is the mastermind of thymus organogenesis and identity [1], and is an acknowledged direct molecular target of the glycolipoprotein Wnt4 [2]. Thymic epithelial cells secrete less Wnt, while their Frizzled receptors (Fz4 and Fz6) become up-regulated indicating a potential compensatory mechanism and possibly enhanced Wnt4-binding [8]. This loss of Wnt expression weakens thymic epithelial identity and allows for thymic adipose involution to occur [9]. This latter process leads to the expansion of thymic adipose tissue orchestrated by transcription factor PPARgamma [10]. We have previously shown that the addition of exogenous Wnt reinforces thymic epithelial identity and confers resistance in a steroid-induced model of senescence through suppressing PPARgamma [2, 14]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.